Cantor Fitzgerald Reiterates Bullish View on Global Blood Therapeutics (GBT) on Accelerated Path for Voxelotor
Tweet Send to a Friend
Cantor Fitzgerald analyst Elemer Piros reiterated an Overweight rating and $96 price target on Global Blood Therapeutics (NASDAQ: GBT) following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
